(Q35684589)

9 August 2017

1 reference

title

Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures (English)

1 reference

9 August 2017

1 reference

Thomas H Kelly

1

1 reference

9 August 2017

William W Stoops

2

1 reference

9 August 2017

Andrea S Perry

3

1 reference

9 August 2017

Mark A Prendergast

4

1 reference

9 August 2017

Craig R Rush

5

1 reference

9 August 2017

language of work or name

1 reference

1 December 2003

1 reference

Behavioral and cognitive neuroscience reviews

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

227-260

1 reference

Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The quantal nature of controlling stimulus-response relations as measured in tests of stimulus generalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

An experimental paradigm for studying the discriminative stimulus properties of drugs in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The discriminative stimulus and subjective effects of d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Drug discrimination in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Interaction of cannabidiol and alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Haloperidol reduces stimulant and reinforcing effects of ethanol in social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Significant interaction between clozapine and cocaine in cocaine addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Utility of subjective-effects measurements in assessing abuse liability of drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The role of dopamine in the behavioral effects of caffeine in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Clinical Pharmacokinetics of the Newer Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of pergolide on intravenous cocaine self-administration in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of cannabis and alcohol on automobile driving and psychomotor tracking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Lorazepam substitutes for the alcohol stimulus in social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Dextroamphetamine-induced arousal in human subjects as a model for mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Drug discrimination by humans compared to nonhumans: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Secobarbital in humans discriminating triazolam under two-response and novel-response procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Discriminative stimulus effects of alcohol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Human d-amphetamine drug discrimination: methamphetamine and hydromorphone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Coffee and caffeine and alcohol effects on psychomotor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Triazolam as a discriminative stimulus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Is tofisopam an atypical anxiolytic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Randomized placebo-controlled trial of the activity of the morphine glucuronides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Influence of training dose on nicotine discrimination in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Threshold doses for nicotine discrimination in smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of training dose and two- versus three-choice testing procedure on nicotine discrimination responding in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Nicotine discrimination and self-administration in humans as a function of smoking status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of central and peripheral nicotinic blockade on human nicotine discrimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mecamylamine reduces some EEG effects of nicotine chewing gum in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Buprenorphine and naloxone alone and in combination in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Discrimination of butorphanol and nalbuphine in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Adenosine receptors in the nervous system: pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Behavioral pharmacology of zolpidem relative to benzodiazepines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Discriminative-stimulus effects of modafinil in cocaine-trained humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Tofisopam, a novel 3,4-benzodiazepine: multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Intravenous cocaine: psychiatric effects, biological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of intravenous cocaine are partially attenuated by haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Comparing single and cumulative dosing procedures in human triazolam discriminators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Ondansetron alters human alcohol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Neuropsychopharmacology at the new millennium: new industry directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of triprolidine and dipipanone in the cold induced pain test, and the central nervous system of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Lack of effects of ethanol pretreatment on the abuse liability of nitrous oxide in light and moderate drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Modulation of intravenous cocaine effects by chronic oral cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Buprenorphine alone and in combination with naloxone in non-dependent humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effect of flumazenil on GABAA receptors in isolated rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of ethanol and nitrous oxide, alone and in combination, on mood, psychomotor performance and pain reports in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

Effects of calcium channel inhibitors on ethanol effects and pharmacokinetics in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534582303262095

21 January 2018

Identifiers

DOI

10.1177/1534582303262095

1 reference

9 August 2017

1 reference